Mets/Jets/Knicks fans are roughly 10% of the NY fan base. For fans like myself who were too young or not alive in '86, this has been a brutal combination. Likely offspring of fans who chose teams in 69/70. That negativivity bias ended last night! #LGK @liam_mchugh @SeanFennessey
Thomas Magaldi retweeted
Congratulations to GSK PhD student Margaret Kennedy in the lab of @LoweLabMSKCC for defending her thesis entitled "Investigating Transcriptional Dysregulation in Disease through Genetic Engineering and Therapeutic Inhibition."
Thomas Magaldi retweeted
Congratulations to #GSK alumnus Zhi (Zach) Zheng from the lab of Scott Keeney, who has been awarded the 2025 Chairman's Prize!
mskcc.org/news/2025-gsk-chai…
Thomas Magaldi retweeted
🎓 Meet 2025 Hertz Fellow Gianfranco Yee, @GSKGradSchool at @MSKCancerCenter 1st-ever #HertzFellow!
@GfrancoYee's research explores the gut microbiome–immune system axis to develop next-gen cancer therapies. 🦠🔬 bit.ly/434Nu87
#CancerResearch #HertzFellow #CancerCare
Thomas Magaldi retweeted
👏 Meet the 2025 Hertz Fellows—19 rising leaders in science and tech advancing breakthroughs in robotics, energy, medicine & more. 🔗Learn more: bit.ly/2025HertzFellows
Thomas Magaldi retweeted
Excited to welcome more amazing faculty to the program! mskcc.org/news/msks-cancer-e… @GSKGradSchool @MSKCancerCenter
Thomas Magaldi retweeted
The @GSKGradSchool at @MSKCancerCenter is now accepting applications for its Cancer Biology and Cancer Engineering programs for the 2025 year. Apply here: bit.ly/3YWHT39
Thomas Magaldi retweeted
Now accepting applications for our 2025 Cancer Biology & Cancer Engineering programs. Aspiring scientists & engineers will solve fundamental problems in biology & conduct research & develop technology that will help understand, diagnose, & treat cancer. bit.ly/3WUiuo1
Thomas Magaldi retweeted
The application deadline is fast approaching! Come join us in the most unique graduate school experience fusing engineering and cancer biology.
We are excited to announce the new Pat and Ian Cook Doctoral Program in Cancer Engineering, a first of its kind led by @KeshariLab and @HellerLab sloankettering.edu/gerstner/… Applications open today. Stay tuned for more to come!
Thomas Magaldi retweeted
GSK has arrived at #2023ABRCMS
@ABRCMS! Come to booth 1110 to learn about our #PhD, #Postbac, and #SummerResearch Programs in #Cancer #Biology and #Engineering @MSKCancerCenter
@MSKEducation
Thomas Magaldi retweeted
#2023NDiSTEM @SACNAS! Come to booth 1341 to learn about our #PhD, #Postbac, and #SummerResearch Programs in #Cancer #Biology and #Engineering @MSKCancerCenter @MSKEducation
Apply NOW for a first-of-its-kind PhD program at @GSKGradSchool to train students to develop new technologies to better understand #biology, and diagnose & treat #cancer. Deadline for The Pat and Ian Cook Doctoral Program in Cancer Engineering is 12/1.
sloankettering.edu/gerstner/…
Thomas Magaldi retweeted
NYC biomedical engineering at #BMES2023! @delazarolab from @NyuBme and @GSKGradSchool Cancer Engineering!
I will presenting at @WCUBPHD #WCUB2023 this year on overcoming common career challenges that PhDs face. This is an amazing event that PhD students and postdocs should consider attending whatcanyoubewithaphd.com
Thomas Magaldi retweeted
Congratulations to GSK PhD student Hongyu Shi in the lab of Nikolaus Schultz and Sohrab Shah, for defending her thesis entitled "Linking Genomic Instability and Phenotypic Dynamics at Single-Cell Resolution in Cancer Cell Populations"
Something weird happens to #NewYorkers when there is a crisis or major disruption to our routines. We talk to each other. Most days we don’t engage. But when we have a common enemy, we become brothers and sisters. #ILoveNewYork #flashflood
Was an excellent talk! Also makes me think @ninatandon would be a great speaker for the @GSKGradSchool new #Cancer #Engineering PhD program. So much amazing science.
This quoted post is unavailable.
Thomas Magaldi retweeted
Replying to @Olivia_Beavers
In the several articles (from Utah sources) that I've read about Stewart's resignation, not one of them mentions that he voted to overthrow the US government in January 2021
Thomas Magaldi retweeted
Congratulations to all of our #GSK PhD students for securing internal and external fellowships over the past year, well done!
mskcc.org/news/gerstner-sloa…
















